SHPG - Shire plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
172.49
-0.25 (-0.14%)
As of 9:46AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close172.74
Open172.46
Bid172.47 x 900
Ask172.51 x 1000
Day's Range172.40 - 172.85
52 Week Range123.73 - 177.51
Volume33,926
Avg. Volume1,360,401
Market Cap52.73B
Beta1.42
PE Ratio (TTM)11.81
EPS (TTM)14.60
Earnings DateN/A
Forward Dividend & Yield1.05 (0.61%)
Ex-Dividend Date2018-03-08
1y Target Est202.00
Trade prices are not sourced from all markets
  • GlobeNewswire8 hours ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire2 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire3 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire7 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • Company News For Jul 11, 2018
    Zacks8 days ago

    Company News For Jul 11, 2018

    Companies In The News are: SHPG,SJM,XRX,PCAR

  • GlobeNewswire8 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • U.S. regulator backs Takeda's $62B acquisition of Shire
    American City Business Journals9 days ago

    U.S. regulator backs Takeda's $62B acquisition of Shire

    In a statement, Takeda said the Federal Trade Commission's approval "is another significant milestone" for the $62 billion deal.

  • Japan's Takeda gains U.S. approval for $62 billion Shire buy
    Reuters9 days ago

    Japan's Takeda gains U.S. approval for $62 billion Shire buy

    Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion (46.9 billion pounds) acquisition of London-listed Shire Plc (SHP.L), taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker. Takeda in a press release said it received unconditional clearance from the United States Federal Trade Commission. The Tokyo-listed firm is still awaiting approval from regulators in China, the European Union and elsewhere, as well from shareholders of both parties.

  • Japan's Takeda gains U.S. approval for $62 billion Shire buy
    Reuters9 days ago

    Japan's Takeda gains U.S. approval for $62 billion Shire buy

    Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker. Takeda in a press release said it received unconditional clearance from the United States Federal Trade Commission. The Tokyo-listed firm is still awaiting approval from regulators in China, the European Union and elsewhere, as well from shareholders of both parties.

  • Takeda Clears Hurdle for $62 Billion Shire Deal
    Bloomberg9 days ago

    Takeda Clears Hurdle for $62 Billion Shire Deal

    Takeda Pharmaceutical Co. cleared a hurdle for its $62 billion acquisition of Shire Plc, receiving unconditional approval from the U.S. Federal Trade Commission two months after sealing its biggest deal ...

  • GlobeNewswire9 days ago

    Shire plc : Rule 2.9 announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire10 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • Is Shire (SHPG) a Great Stock for Value Investors?
    Zacks14 days ago

    Is Shire (SHPG) a Great Stock for Value Investors?

    Let's put Shire (SHPG) stock into this equation and find out if it is a good choice for value-oriented investors right now.

  • GlobeNewswire14 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire15 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire16 days ago

    Shire plc : Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. ...

  • GlobeNewswire17 days ago

    Shire plc : Total voting rights

    Total Voting Rights July 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority`s (the "FCA") Disclosure Guidance ...

  • GlobeNewswire17 days ago

    Shire plc: Director/PDMR Shareholding

    Director/PDMR Shareholding   July 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG)   Notification of transactions by persons discharging managerial responsibilities   1. Details of the person discharging managerial ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - Gail Fosler

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - Sara Mathew

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - David Ginsburg

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - Olivier Bohuon

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - Albert Stroucken

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : Form 8 (DD) - Steven Gillis

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover ...

  • GlobeNewswire17 days ago

    Shire plc : CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI(R) FOR ADULTS WITH VON WILLEBRAND DISEASE

    CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI ® FOR ADULTS WITH VON WILLEBRAND DISEASE If approved, VEYVONDI ® [ vonicog alfa, recombinant von ...